259 related articles for article (PubMed ID: 14665670)
1. The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo.
Relaix F; Polimeni M; Rocancourt D; Ponzetto C; Schäfer BW; Buckingham M
Genes Dev; 2003 Dec; 17(23):2950-65. PubMed ID: 14665670
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome analyses based on genetic screens for Pax3 myogenic targets in the mouse embryo.
Lagha M; Sato T; Regnault B; Cumano A; Zuniga A; Licht J; Relaix F; Buckingham M
BMC Genomics; 2010 Dec; 11():696. PubMed ID: 21143873
[TBL] [Abstract][Full Text] [Related]
3. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
Sublett JE; Jeon IS; Shapiro DN
Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639
[TBL] [Abstract][Full Text] [Related]
4. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene.
Fredericks WJ; Ayyanathan K; Herlyn M; Friedman JR; Rauscher FJ
Mol Cell Biol; 2000 Jul; 20(14):5019-31. PubMed ID: 10866659
[TBL] [Abstract][Full Text] [Related]
5. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene.
Khan J; Bittner ML; Saal LH; Teichmann U; Azorsa DO; Gooden GC; Pavan WJ; Trent JM; Meltzer PS
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13264-9. PubMed ID: 10557309
[TBL] [Abstract][Full Text] [Related]
6. Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors.
Lagutina I; Conway SJ; Sublett J; Grosveld GC
Mol Cell Biol; 2002 Oct; 22(20):7204-16. PubMed ID: 12242297
[TBL] [Abstract][Full Text] [Related]
7. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3.
Fredericks WJ; Galili N; Mukhopadhyay S; Rovera G; Bennicelli J; Barr FG; Rauscher FJ
Mol Cell Biol; 1995 Mar; 15(3):1522-35. PubMed ID: 7862145
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mice expressing PAX3-FKHR have multiple defects in muscle development, including ectopic skeletal myogenesis in the developing neural tube.
Finckenstein FG; Davicioni E; Osborn KG; Cavenee WK; Arden KC; Anderson MJ
Transgenic Res; 2006 Oct; 15(5):595-614. PubMed ID: 16952014
[TBL] [Abstract][Full Text] [Related]
9. Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.
Keller C; Hansen MS; Coffin CM; Capecchi MR
Genes Dev; 2004 Nov; 18(21):2608-13. PubMed ID: 15520281
[TBL] [Abstract][Full Text] [Related]
10. Rib truncations and fusions in the Sp2H mouse reveal a role for Pax3 in specification of the ventro-lateral and posterior parts of the somite.
Henderson DJ; Conway SJ; Copp AJ
Dev Biol; 1999 May; 209(1):143-58. PubMed ID: 10208749
[TBL] [Abstract][Full Text] [Related]
11. Divergent functions of murine Pax3 and Pax7 in limb muscle development.
Relaix F; Rocancourt D; Mansouri A; Buckingham M
Genes Dev; 2004 May; 18(9):1088-105. PubMed ID: 15132998
[TBL] [Abstract][Full Text] [Related]
12. PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro.
Armoni M; Quon MJ; Maor G; Avigad S; Shapiro DN; Harel C; Esposito D; Goshen Y; Yaniv I; Karnieli E
J Clin Endocrinol Metab; 2002 Nov; 87(11):5312-24. PubMed ID: 12414908
[TBL] [Abstract][Full Text] [Related]
13. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
Barr FG
Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein.
Xia SJ; Barr FG
Oncogene; 2004 Sep; 23(41):6864-71. PubMed ID: 15286710
[TBL] [Abstract][Full Text] [Related]
15. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C
Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR.
Margue CM; Bernasconi M; Barr FG; Schäfer BW
Oncogene; 2000 Jun; 19(25):2921-9. PubMed ID: 10871843
[TBL] [Abstract][Full Text] [Related]
17. A genetic analysis of PAX3-FKHR, the oncogene of alveolar rhabdomyosarcoma.
Kempf BE; Vogt PK
Cell Growth Differ; 1999 Dec; 10(12):813-8. PubMed ID: 10616906
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific PAX3-FKHR transcription factor, but not PAX3, activates the platelet-derived growth factor alpha receptor.
Epstein JA; Song B; Lakkis M; Wang C
Mol Cell Biol; 1998 Jul; 18(7):4118-30. PubMed ID: 9632796
[TBL] [Abstract][Full Text] [Related]
19. Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene.
Ayyanathan K; Fredericks WJ; Berking C; Herlyn M; Balakrishnan C; Gunther E; Rauscher FJ
Cancer Res; 2000 Oct; 60(20):5803-14. PubMed ID: 11059777
[TBL] [Abstract][Full Text] [Related]
20. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains.
Bennicelli JL; Fredericks WJ; Wilson RB; Rauscher FJ; Barr FG
Oncogene; 1995 Jul; 11(1):119-30. PubMed ID: 7624119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
